Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Amengual

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Modern Rheumatology|August 26, 2024
Phosphatidylserine-dependent antiprothrombin antibodies as a key predictor for systemic lupus erythematosus in patients with primary antiphospholipid syndrome: A retrospective longitudinal cohort studyJiang Wei, Yuichiro Fujieda, Yusuke Fujita, et al.
Arthritis and Rheumatism|September 29, 2011
Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic eventsKotaro Otomo, Tatsuya Atsumi, Olga Amengual, et al.
Lupus|June 23, 2026
Longitudinal observation of thrombotic events in patients with obstetric antiphospholipid syndromeYuta Inoue, Hiroyuki Nakamura, Yuichiro Fujieda, et al.
Rheumatology (Oxford, England)|December 6, 2025
The increase of monocyte/high-density lipoprotein cholesterol ratio precedes recurrent thrombosis in patients with antiphospholipid syndromeHaruka Moriya, Ryo Hisada, Yuichiro Fujieda, et al.
Arthritis Care & Research|July 8, 2017
First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β<sub>2</sub> -Glycoprotein I Domain I and Anti-Phosphatidylserine/Prothrombin Complex Antibodies TestsHiroyuki Nakamura, Kenji Oku, Olga Amengual, et al.
CEN Case Reports|June 27, 2025
Reduction of polycystic kidney and liver volumes in a patient with tolvaptan-resistant autosomal dominant polycystic kidney disease and acromegaly during lanreotide therapyShun Takenaka, Fumihiko Hattanda, Takuro Kawamura, et al.
International Immunology|October 7, 2004
The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodiesMiyuki Bohgaki, Tatsuya Atsumi, Yumi Yamashita, et al.
Rheumatology (Oxford, England)|April 17, 2016
Autoantibodies against a complement component 1 q subcomponent contribute to complement activation and recurrent thrombosis/pregnancy morbidity in anti-phospholipid syndromeKenji Oku, Olga Amengual, Ryo Hisada, et al.
Rheumatology (Oxford, England)|December 7, 2018
Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosusRyo Hisada, Masaru Kato, Naoki Ohnishi, et al.
Autoimmunity Reviews|August 4, 2016
Complement and thrombosis in the antiphospholipid syndromeKenji Oku, Hiroyuki Nakamura, Michihiro Kono, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Modern Rheumatology|August 26, 2024
Phosphatidylserine-dependent antiprothrombin antibodies as a key predictor for systemic lupus erythematosus in patients with primary antiphospholipid syndrome: A retrospective longitudinal cohort studyJiang Wei, Yuichiro Fujieda, Yusuke Fujita, et al.
Arthritis and Rheumatism|September 29, 2011
Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic eventsKotaro Otomo, Tatsuya Atsumi, Olga Amengual, et al.
Lupus|June 23, 2026
Longitudinal observation of thrombotic events in patients with obstetric antiphospholipid syndromeYuta Inoue, Hiroyuki Nakamura, Yuichiro Fujieda, et al.
Rheumatology (Oxford, England)|December 6, 2025
The increase of monocyte/high-density lipoprotein cholesterol ratio precedes recurrent thrombosis in patients with antiphospholipid syndromeHaruka Moriya, Ryo Hisada, Yuichiro Fujieda, et al.
Arthritis Care & Research|July 8, 2017
First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β<sub>2</sub> -Glycoprotein I Domain I and Anti-Phosphatidylserine/Prothrombin Complex Antibodies TestsHiroyuki Nakamura, Kenji Oku, Olga Amengual, et al.
CEN Case Reports|June 27, 2025
Reduction of polycystic kidney and liver volumes in a patient with tolvaptan-resistant autosomal dominant polycystic kidney disease and acromegaly during lanreotide therapyShun Takenaka, Fumihiko Hattanda, Takuro Kawamura, et al.
International Immunology|October 7, 2004
The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodiesMiyuki Bohgaki, Tatsuya Atsumi, Yumi Yamashita, et al.
Rheumatology (Oxford, England)|April 17, 2016
Autoantibodies against a complement component 1 q subcomponent contribute to complement activation and recurrent thrombosis/pregnancy morbidity in anti-phospholipid syndromeKenji Oku, Olga Amengual, Ryo Hisada, et al.
Rheumatology (Oxford, England)|December 7, 2018
Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosusRyo Hisada, Masaru Kato, Naoki Ohnishi, et al.
Autoimmunity Reviews|August 4, 2016
Complement and thrombosis in the antiphospholipid syndromeKenji Oku, Hiroyuki Nakamura, Michihiro Kono, et al.
Pageof 8